HAVCR2 and acute myeloid leukemia: In addition, T cells from the patients with AML have increased expression of inhibitory checkpoint molecules including PD-1, Tim-3, and Lag3 compared to T cells from healthy donors, contributing to immune exhaustion and possible AML disease relapse [98].